Mu Z. Hao

State Key Lab Of Experimental Hematology
Tianjin, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications

Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemia.

Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemia.

Journal: Blood
Published: October 29, 2025

Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemia.

Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemia.

Journal: Blood
Published: October 29, 2025

Proteogenomic features define subtypes of mantle cell lymphoma.

Proteogenomic features define subtypes of mantle cell lymphoma.

Journal: Blood advances
Published: October 09, 2025

Proteogenomic features define subtypes of mantle cell lymphoma.

Proteogenomic features define subtypes of mantle cell lymphoma.

Journal: Blood advances
Published: October 09, 2025

Prognostic significance of clinical risk models and genomic alterations in Waldenström macroglobulinemia before or after the BTK inhibitor era.

Prognostic significance of clinical risk models and genomic alterations in Waldenström macroglobulinemia before or after the BTK inhibitor era.

Journal: Leukemia
Published: August 10, 2025

Type I Interferon Pathway Activation Disrupts Monocyte Maturation and Enhances Immune Evasion in Multiple Myeloma.

Type I Interferon Pathway Activation Disrupts Monocyte Maturation and Enhances Immune Evasion in Multiple Myeloma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 12, 2025

Optimal CAR-T cell therapy options for patients with multiple myeloma.

Optimal CAR-T cell therapy options for patients with multiple myeloma.

Journal: Chinese medical journal
Published: May 18, 2025

Identification and transformation of novel targets for immunotherapy in multiple myeloma.

Identification and transformation of novel targets for immunotherapy in multiple myeloma.

Journal: Chinese medical journal
Published: March 30, 2025

Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma.

Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma.

Journal: The Journal of clinical investigation
Published: March 17, 2025

Improving predictive accuracy in multiple myeloma using a plasma cell profile derived from single-cell RNA sequencing.

Improving predictive accuracy in multiple myeloma using a plasma cell profile derived from single-cell RNA sequencing.

Journal: Haematologica
Published: February 17, 2025

The specific transcriptional profile and clonal selection of monoclonal gammopathy of undetermined significancelike behavior predict an exceptionally favorable prognosis in multiple myeloma.

The specific transcriptional profile and clonal selection of monoclonal gammopathy of undetermined significancelike behavior predict an exceptionally favorable prognosis in multiple myeloma.

Journal: Haematologica
Published: February 06, 2025

Progress in risk stratification and treatment of high-risk smoldering multiple myeloma

Progress in risk stratification and treatment of high-risk smoldering multiple myeloma

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: January 07, 2025
Showing 1-12 of 89

Last Updated: 09/26/2026